News / Health

    Synthetic Malaria Drug Made Through Biotech, Yeast

    A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
    A young girl with malaria rests in the inpatient ward of the Malualkon Primary Health Care Center in Malualkon, in the South Sudanese state of Northern Bahr el-Ghazal, June 1, 2012.
    Jessica Berman
    The World Health Organization says more than 200 million people - mostly in sub-Saharan Africa - were infected with malaria in 2010.  The mosquito-borne parasitic illness annually kills 650,000 people, a majority of them young children.

    The most effective anti-malaria treatment developed so far is artemisinin, a plant-derived drug that is expensive and often unavailable.  Now, after a decade-long research effort, scientists have found a novel way to cheaply mass-produce artemisinin. The new, bio-synthetic version of the drug could be a major advance in the battle against malaria.

    Whenever he travels to Africa, Jack Newman says he arrives prepared with his own supply of artemisinin.

    “I always keep it in my back pocket in case I get malaria," said Newman. "Again, in three days you are cured.”

    The American researcher hopes others infected with the parasitic illness might soon have easy access to the drug, too.

    Newman is co-founder of Amyris, a U.S. biotechnology company that, in collaboration with researchers at the University of California Berkeley and the Canadian National Research Council, developed a process for making large quantities of a semi-synthetic version of artemisinin, offering people with uncomplicated malaria a cure in just three days.  

    Artemisinin is a compound that until now has been derived exclusively from an ancient, bitter herb called wormwood.  It is up to 95 percent effective in curing uncomplicated malaria infections but, because it is derived from a plant, artemisinin is frequently in short supply, and expensive.

    Newman and his colleagues figured out a way to make an unlimited supply of artemisinin using a technique that combines biotechnology and a simple yeast fermentation process.  

    He says they extracted DNA from the wormwood plant and inserted it into yeast cells …

    “..to fire up a big fermentation, like beer fermentation, but instead of making beer, you are actually making [an] anti-malarial drug," he said. "And you can do it in hundreds of thousands of gallons and, of course, make it in an industrial fashion, the same way we make penicillin;  very, very inexpensively.”

    The process yields a chemical precursor to artemisinin, which is used in the production of the drug.

    The innovation was made possible in large part by grants totaling $53.3 million from the Bill and Melinda Gates Foundation to the drug development arm of PATH, an international non-profit group that has been leading the fight against malaria and other diseases.  PATH helped move the artemisinin research out of the UC Berkeley labs to Amyris for scale-up, and then to the pharmaceutical company Sanofi Pasteur, for production of the yeast-based artemisinin. The company says it is distributing the drug free of charge.

    Sanofi also plans to share the recipe with other drug makers so they, too, can use the technology to manufacture and distribute it on a “no profit, no loss” basis, according to Amyris's Jack Newman.

    “Basically, by using synthetic biology, we’ve been able to stabilize the production so there’s always material available and make it at a very low cost," he said.

    Newman says the yeast-based drug is identical to plant-derived artemisinin in terms of effectiveness. It is being formulated with a second anti-malaria compound to reduce the chances of drug resistance.

    So far, Newman says, Sanofi plans to make 70 million doses of what he calls malaria “cures” this year. Using synthetic biology, next year the company will scale up production to 120 million doses, which will be distributed globally pending World Health Organization approval.

    Jack Newman and his colleagues describe their production of a semi-synthetic version of the anti-malarial drug artemisinin in an article published in the journal Nature.  

    You May Like

    Hope Remains for Rio Olympic Games

    Facing a host of problems, Rio prepares for holding the games but experts say some risks, like Zika, may not be as grave as initially thought

    IS Use of Social Media to Recruit, Radicalize Still a Top Threat to US

    Despite military gains against IS in Iraq and Syria, their internet propaganda still commands an audience; US officials see 'the most complex challenge that the federal government and industry face'

    ‘Time Is Now’ to Save Africa’s Animals From Poachers, Activist Says

    During Zimbabwe visit, African Wildlife Foundation President Kaddu Sebunya says poaching hurts Africa as slave trade once did

    Featured Videos

    Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
    Ivorian Chocolate Makers Promote Locally-made Chocolatei
    X
    July 29, 2016 4:02 PM
    Ivory Coast is the world's top producer of cocoa but hardly any of it is processed into chocolate there. Instead, the cocoa is sent abroad to chocolate makers in Europe and elsewhere. This is a general problem throughout Africa – massive exports of raw materials but few finished goods. As Emilie Iob reports from Abidjan, several Ivorian entrepreneurs are working to change that formula - 100 percent Ivorian chocolate bar at a time.
    Video

    Video Ivorian Chocolate Makers Promote Locally-made Chocolate

    Ivory Coast is the world's top producer of cocoa but hardly any of it is processed into chocolate there. Instead, the cocoa is sent abroad to chocolate makers in Europe and elsewhere. This is a general problem throughout Africa – massive exports of raw materials but few finished goods. As Emilie Iob reports from Abidjan, several Ivorian entrepreneurs are working to change that formula - 100 percent Ivorian chocolate bar at a time.
    Video

    Video Tesla Opens Battery-Producing Gigafactory

    Two years after starting to produce electric cars, U.S. car maker Tesla Motors has opened the first part of its huge battery manufacturing plant, which will eventually cover more than a square kilometer. Situated close to Reno, Nevada, the so-called Gigafactory will eventually produce more lithium-ion batteries than were made worldwide in 2013. VOA's George Putic reports.
    Video

    Video Polio-affected Afghan Student Fulfilling Her Dreams in America

    Afghanistan is one of only two countries in the world where children still get infected by polio. The other is Pakistan. Mahbooba Akhtarzada who is from Afghanistan, was disabled by polio, but has managed to overcome the obstacles caused by this crippling disease. VOA's Zheela Nasari caught up with Akhtarzada and brings us this report narrated by Bronwyn Benito.
    Video

    Video Hillary Clinton Promises to Build a 'Better Tomorrow'

    Democratic presidential candidate Hillary Clinton urged voters Thursday not to give in to the politics of fear. She vowed to unite the country and move it forward if elected in November. Clinton formally accepted the Democratic Party's nomination at its national convention in Philadelphia. VOA national correspondent Jim Malone has more.
    Video

    Video Trump Tones Down Praise for Russia

    Republican presidential candidate Donald Trump is toning down his compliments for Russia and Vladimir Putin as such rhetoric got him in trouble recently. After calling on Russia to find 30.000 missing emails from rival Hillary Clinton, Trump told reporters he doesn't know Putin and never called him a great leader, just one who's better than President Barack Obama. Putin has welcomed Trump's overtures, but, as Zlatica Hoke reports, ordinary Russians say they are not putting much faith in Trump.
    Video

    Video Uganda Unveils its First Solar-powered Bus

    A solar-powered bus described by its Ugandan makers as the first in Africa has made its public debut. Kiira Motors' electric bus, Kayoola, displayed recently at a stadium in Uganda's capital. From Kampala, Maurice Magorane filed this report narrated by Salem Solomon.
    Video

    Video Silicon Valley: More Than A Place, It's a Culture

    Silicon Valley is a technology powerhouse and a place that companies such as Google, Facebook and Apple call home. It is a region in northern California that stretches from San Francisco to San Jose. But, more than that, it's known for its startup culture. VOA's Elizabeth Lee went inside one company to find out what it's like to work in a startup.
    Video

    Video Immigrant Delegate Marvels at Democratic Process

    It’s been a bitter and divisive election season – but first time Indian-American delegate Dr. Shashi Gupta headed to the Democratic National Convention with a sense of hope. VOA’s Katherine Gypson followed this immigrant with the love of U.S. politics all the way to Philadelphia.
    Video

    Video Dutch Entrepreneurs Turn Rainwater Into Beer

    June has been recorded as one of the wettest months in more than a century in many parts of Europe. To a group of entrepreneurs in Amsterdam the rain came as a blessing, as they used the extra water to brew beer. Serginho Roosblad has more to the story.
    Video

    Video Commerce Thrives on US-Mexico Border

    At the Democratic Convention in Philadelphia this week, the party’s presumptive presidential nominee, Hillary Clinton, is expected to attack proposals made by her opponent, Republican presidential nominee Donald Trump, to build a wall along the U.S.-Mexico border. Last Friday, President Barack Obama hosted his Mexican counterpart, President Enrique Peña Nieto, to underscore the good relations between the two countries. VOA’s Greg Flakus reports from Tucson.
    Video

    Video Film Helps Save Ethiopian Children Thought to be Cursed

    'Omo Child' looks at effort of African man to stop killings of ‘mingi’ children
    Video

    Video London’s Financial Crown at Risk as Rivals Eye Brexit Opportunities

    By most measures, London rivals New York as the only true global financial center. But Britain’s vote to leave the European Union – so-called ‘Brexit’ – means the city could lose its right to sell services tariff-free across the bloc, risking its position as Europe’s financial headquarters. Already some banks have said they may shift operations to the mainland. Henry Ridgwell reports from London.

    Special Report

    Adrift The Invisible African Diaspora